IPHA peer analysis
Innate Pharma (IPHA) against its competitors: price, today's move, 1-year return and market value side by side.
- IPHA's peers: CGEN (Compugen), CRBP (Corbus), CRDF (Cardiff Oncology), ELTX (Elicio), MIST (Milestone Pharmaceuticals), MOLN (Molecular Partners), NVCT (Nuvectis Pharma), RANI (Rani Therapeutics).
IPHA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CGEN Compugen | $1.88 | -4.08% | 17.50% | $178.08M |
| CRBP Corbus | $2.09 | -14.17% | -82.32% | $43.07M |
| CRDF Cardiff Oncology | $0.84 | -6.37% | -58.21% | $65.01M |
| ELTX Elicio | $1.50 | -5.66% | -81.48% | $42.46M |
| MIST Milestone Pharmaceuticals | $0.40 | -13.27% | -82.86% | $49.71M |
| MOLN Molecular Partners | $2.67 | -6.82% | – | $102.16M |
| NVCT Nuvectis Pharma | $19.41 | -2.17% | 225.13% | $667.49M |
| RANI Rani Therapeutics | $0.58 | -10.42% | -66.82% | $80.97M |
| IPHA Innate Pharma | $0.94 | -8.75% | -47.78% | $104.99M |